Gene Page: HMGN1
Summary ?
GeneID | 3150 |
Symbol | HMGN1 |
Synonyms | HMG14 |
Description | high mobility group nucleosome binding domain 1 |
Reference | MIM:163920|HGNC:HGNC:4984|Ensembl:ENSG00000205581|HPRD:01231|Vega:OTTHUMG00000066178 |
Gene type | protein-coding |
Map location | 21q22.2 |
Pascal p-value | 0.013 |
Sherlock p-value | 0.713 |
eGene | Caudate basal ganglia Cerebellum Myers' cis & trans Meta |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs2836921 | chr21 | 40516069 | HMGN1 | 3150 | 0.05 | cis | ||
rs8132295 | chr21 | 40527773 | HMGN1 | 3150 | 0.07 | cis | ||
rs8132333 | chr21 | 40527899 | HMGN1 | 3150 | 0.08 | cis | ||
rs7279497 | chr21 | 40531305 | HMGN1 | 3150 | 0 | cis | ||
rs8132424 | chr21 | 40584411 | HMGN1 | 3150 | 9.164E-4 | cis | ||
rs2150413 | chr21 | 40614877 | HMGN1 | 3150 | 0 | cis | ||
rs2150414 | chr21 | 40614987 | HMGN1 | 3150 | 0.01 | cis | ||
rs2150415 | chr21 | 40615366 | HMGN1 | 3150 | 0.06 | cis | ||
rs2836956 | chr21 | 40623017 | HMGN1 | 3150 | 0 | cis | ||
rs1541102 | chr21 | 40628764 | HMGN1 | 3150 | 0.09 | cis | ||
rs2836974 | chr21 | 40663180 | HMGN1 | 3150 | 0.06 | cis | ||
rs2735306 | chr21 | 40713133 | HMGN1 | 3150 | 0.1 | cis | ||
rs2836992 | chr21 | 40735605 | HMGN1 | 3150 | 0 | cis | ||
rs7279497 | chr21 | 40531305 | HMGN1 | 3150 | 0.15 | trans | ||
rs8132424 | chr21 | 40584411 | HMGN1 | 3150 | 0.07 | trans | ||
rs2150413 | chr21 | 40614877 | HMGN1 | 3150 | 0.17 | trans | ||
rs2836956 | chr21 | 40623017 | HMGN1 | 3150 | 0.1 | trans | ||
rs2836992 | chr21 | 40735605 | HMGN1 | 3150 | 0.09 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
BIOCARTA P38MAPK PATHWAY | 40 | 31 | All SZGR 2.0 genes in this pathway |
MARKEY RB1 ACUTE LOF DN | 228 | 137 | All SZGR 2.0 genes in this pathway |
OUELLET OVARIAN CANCER INVASIVE VS LMP UP | 117 | 85 | All SZGR 2.0 genes in this pathway |
HU ANGIOGENESIS DN | 37 | 25 | All SZGR 2.0 genes in this pathway |
SCHLOSSER SERUM RESPONSE DN | 712 | 443 | All SZGR 2.0 genes in this pathway |
DAWSON METHYLATED IN LYMPHOMA TCL1 | 59 | 45 | All SZGR 2.0 genes in this pathway |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP | 479 | 299 | All SZGR 2.0 genes in this pathway |
PUJANA XPRSS INT NETWORK | 168 | 103 | All SZGR 2.0 genes in this pathway |
PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | All SZGR 2.0 genes in this pathway |
PUJANA BRCA2 PCC NETWORK | 423 | 265 | All SZGR 2.0 genes in this pathway |
PUJANA ATM PCC NETWORK | 1442 | 892 | All SZGR 2.0 genes in this pathway |
PUJANA CHEK2 PCC NETWORK | 779 | 480 | All SZGR 2.0 genes in this pathway |
ALCALA APOPTOSIS | 88 | 60 | All SZGR 2.0 genes in this pathway |
ROZANOV MMP14 TARGETS UP | 266 | 171 | All SZGR 2.0 genes in this pathway |
ZUCCHI METASTASIS DN | 44 | 29 | All SZGR 2.0 genes in this pathway |
WONG IFNA2 RESISTANCE DN | 34 | 20 | All SZGR 2.0 genes in this pathway |
FLECHNER BIOPSY KIDNEY TRANSPLANT OK VS DONOR UP | 555 | 346 | All SZGR 2.0 genes in this pathway |
BROWN MYELOID CELL DEVELOPMENT DN | 129 | 86 | All SZGR 2.0 genes in this pathway |
MOREIRA RESPONSE TO TSA UP | 28 | 23 | All SZGR 2.0 genes in this pathway |
BAELDE DIABETIC NEPHROPATHY DN | 434 | 302 | All SZGR 2.0 genes in this pathway |
HU GENOTOXIC DAMAGE 4HR | 35 | 28 | All SZGR 2.0 genes in this pathway |
LEE CALORIE RESTRICTION MUSCLE DN | 51 | 28 | All SZGR 2.0 genes in this pathway |
GRADE COLON CANCER UP | 871 | 505 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER SURVIVAL DN | 175 | 103 | All SZGR 2.0 genes in this pathway |
SWEET LUNG CANCER KRAS UP | 491 | 316 | All SZGR 2.0 genes in this pathway |
CAIRO LIVER DEVELOPMENT UP | 166 | 105 | All SZGR 2.0 genes in this pathway |
KAMMINGA SENESCENCE | 41 | 26 | All SZGR 2.0 genes in this pathway |
MARTENS TRETINOIN RESPONSE DN | 841 | 431 | All SZGR 2.0 genes in this pathway |
KIM ALL DISORDERS OLIGODENDROCYTE NUMBER CORR UP | 756 | 494 | All SZGR 2.0 genes in this pathway |
KIM BIPOLAR DISORDER OLIGODENDROCYTE DENSITY CORR UP | 682 | 440 | All SZGR 2.0 genes in this pathway |
PILON KLF1 TARGETS DN | 1972 | 1213 | All SZGR 2.0 genes in this pathway |
JOHNSTONE PARVB TARGETS 3 DN | 918 | 550 | All SZGR 2.0 genes in this pathway |
BAKKER FOXO3 TARGETS DN | 187 | 109 | All SZGR 2.0 genes in this pathway |
FEVR CTNNB1 TARGETS DN | 553 | 343 | All SZGR 2.0 genes in this pathway |
TERAO AOX4 TARGETS SKIN UP | 38 | 27 | All SZGR 2.0 genes in this pathway |